RUNNING TITLE : diabetes and stem cell angiogenic response

[1]  R. Rahbarghazi,et al.  Chronic Exposure of Human Endothelial Progenitor Cells to Diabetic Condition Abolished the Regulated Kinetics Activity of Exosomes , 2018, Iranian journal of pharmaceutical research : IJPR.

[2]  R. Rahbarghazi,et al.  Type 2 Diabetes Inhibited Human Mesenchymal Stem Cells Angiogenic Response by Over‐Activity of the Autophagic Pathway , 2017, Journal of cellular biochemistry.

[3]  Yue Cao,et al.  Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer , 2017, Journal of diabetes research.

[4]  H. Petite,et al.  Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties , 2016, Journal of cellular and molecular medicine.

[5]  D. Agrawal,et al.  Effects of matrix metalloproteinases on the fate of mesenchymal stem cells , 2016, Stem Cell Research & Therapy.

[6]  H. Baharvand,et al.  Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes , 2015, Scientific Reports.

[7]  K. Alitalo,et al.  Endothelial destabilization by angiopoietin-2 via integrin β1 activation , 2015, Nature Communications.

[8]  Y. Liu,et al.  Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells , 2013, PloS one.

[9]  G. Doronzo,et al.  Effects of High Glucose on Vascular Endothelial Growth Factor Synthesis and Secretion in Aortic Vascular Smooth Muscle Cells from Obese and Lean Zucker Rats , 2012, International journal of molecular sciences.

[10]  H. Mizuno.  Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials. , 2010, Current opinion in molecular therapeutics.

[11]  Heesang Song,et al.  Modification of mesenchymal stem cells for cardiac regeneration , 2010, Expert opinion on biological therapy.

[12]  Biao Xu,et al.  Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. , 2009, Biochemical and biophysical research communications.

[13]  J. Zweier,et al.  High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling , 2008, Journal of cellular and molecular medicine.

[14]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  R. Rahbarghazi,et al.  Interactions of mesenchymal stem cells with endothelial cells. , 2014, Stem cells and development.

[16]  C. Liang,et al.  Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways , 2008, Basic Research in Cardiology.